Structure-Aware Compound-Protein Affinity Prediction via Graph Neural Networks with Group Lasso Regularization
📰 ArXiv cs.AI
Learn to predict compound-protein affinity using graph neural networks with group Lasso regularization for improved drug discovery
Action Steps
- Build a graph neural network model to predict compound-protein affinity
- Apply group Lasso regularization to the model to improve explainability
- Configure the model to handle limited compound-protein interaction data
- Test the model on a dataset of compound-protein interactions
- Compare the performance of the model with other state-of-the-art methods
Who Needs to Know This
Data scientists and researchers in the pharmaceutical industry can benefit from this approach to accelerate drug discovery and improve molecular representation learning
Key Insight
💡 Graph neural networks with group Lasso regularization can improve the accuracy and explainability of compound-protein affinity prediction
Share This
🧬💻 Predict compound-protein affinity with graph neural networks and group Lasso regularization! #drugdiscovery #AI
Key Takeaways
Learn to predict compound-protein affinity using graph neural networks with group Lasso regularization for improved drug discovery
Full Article
Title: Structure-Aware Compound-Protein Affinity Prediction via Graph Neural Networks with Group Lasso Regularization
Abstract:
arXiv:2507.03318v3 Announce Type: replace-cross Abstract: Explainable artificial intelligence approaches accelerate drug discovery by improving molecular representation learning, identifying key molecular structures, and rationalizing drug property prediction. However, developing end-to-end explainable models for target-specific structure-activity relationship modeling remains challenging because compound-protein interaction data are often limited for individual targets, and small changes in che
Abstract:
arXiv:2507.03318v3 Announce Type: replace-cross Abstract: Explainable artificial intelligence approaches accelerate drug discovery by improving molecular representation learning, identifying key molecular structures, and rationalizing drug property prediction. However, developing end-to-end explainable models for target-specific structure-activity relationship modeling remains challenging because compound-protein interaction data are often limited for individual targets, and small changes in che
DeepCamp AI